UBS tips the Audinate share price could hit $9.45

Audinate Ltd (ASX: AD8): buy, hold, sell?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's one of the most widely fancied shares amongst small-cap enthusiasts in 2019 and today the sell-side research desk at UBS joined the party by giving sound processing business Audinate Ltd (ASX: AD8) a $9.45 share price target.

That means it has plenty of room to run higher from today's price of $7.36 if UBS is on the money with its 12-month share price target.

I must admit I haven't had the time to look into this high-flying small cap in much depth or value it, but below is a re-cap for investors on what the business model is.

Audinate's key product is its Dante enabled audio equipment that improves sound quality when installed in standard audio equipment.

The company's hardware and software allows professional audio equipment (speakers, mixers, mics, etc) to carry audio signals over a computer network, rather than using analog cables.

The advantage of this is that audio professionals can deploy audio solutions using existing computer networks instead of running analog cables throughout a building or venue.

Audinate reportedly also has a strong competitive position as its Dante product is preferred by audio equipment manufacturers, which all suggests the future is bright.

Foolish takeaway

Including shares due to come out of escrow on 30 June 2019, Audinate has around 61.3 million shares on issue to give it a $450 million market value with a $7.35 share price.

Given it posted an operating cash profit (ex-investing expenses, etc) of $2.16 million on revenue of $20.2 million for the nine months ending March 31 2019 we can see that the market and UBS are baking in a lot of growth to its valuation.

I expect the stock will be volatile in the 12 months ahead.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

man with dog on his lap looking at his phone in his home.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »